Stocks and InvestingStocks and Investing
Tue, June 25, 2024
Mon, June 24, 2024
Fri, June 21, 2024

Yasmeen Rahimi Maintained (ALT) at Buy and Held Target at $25 on, Jun 21st, 2024


Published on 2024-10-28 12:02:49 - WOPRAI, Yasmeen Rahimi
  Print publication without navigation


Yasmeen Rahimi of Piper Sandler, Maintained "Altimmune, Inc." (ALT) at Buy and Held Target at $25 on, Jun 21st, 2024.

Yasmeen has made no other calls on ALT in the last 4 months.



There are 4 other peers that have a rating on ALT. Out of the 4 peers that are also analyzing ALT, 1 agrees with Yasmeen's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Seamus Fernandez of "Guggenheim" Downgraded from Strong Buy to Hold on, Monday, April 29th, 2024


These are the ratings of the 3 analyists that currently disagree with Yasmeen


  • Patrick Trucchio of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $12 on, Tuesday, May 14th, 2024
  • Jonathan Wolleben of "JMP Securities" Maintained at Buy with Decreased Target to $24 on, Friday, May 10th, 2024
  • Mayank Mamtani of "B. Riley Securities" Reiterated at Strong Buy and Held Target at $20 on, Thursday, March 28th, 2024